Nidan Laboratories and Healthcare has announced a board meeting on May 28, 2025, approving the audited financial results for the year ended March 31, 2025, with a clean audit opinion. The board also appointed Pusalkar & Co. as Secretarial Auditor for the next five years, subject to shareholder approval. No dividend or fundraising moves were made, signaling a focus on strengthening governance and transparency.
All announcements from Nidan Laboratories and Healthcare Limited